Venous thromboembolism · 5 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Enoxaparin monotherapy Variant #01 | — | R 54 916 | 14d | — | — | ~1 | ~R 54 916 indirect | — |
Apixaban monotherapy Variant #05 | — | R 84 | 180d | — | — | ~1 | ~R 84 indirect | — |
Aspirin monotherapy Variant #01 | — | R 26 | 28d | — | — | ~2 | ~R 52 indirect | — |
Warfarin monotherapy Variant #01 Partial | — | — | 28d | — | — | ~2 | — | — |
Dalteparin monotherapy Variant #01 Partial | — | — | 30d | — | — | ~11 | — | — |
5 of 5 regimens shown